AMNEAL 1171 Pill - yellow capsule/oblong, 18mm
Pill with imprint AMNEAL 1171 is Yellow, Capsule/Oblong and has been identified as Doxepin Hydrochloride 50 mg. It is supplied by Amneal Pharmaceuticals LLC.
Doxepin is used in the treatment of Insomnia; Anxiety; Depression; Urticaria; Major Depressive Disorder and belongs to the drug classes miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants. FDA has not classified the drug for risk during pregnancy. Doxepin 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AMNEAL 1171
Doxepin Hydrochloride
- Imprint
- AMNEAL 1171
- Strength
- 50 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics, Tricyclic antidepressants
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 69238-1171
- Inactive Ingredients
-
ammonia,
microcrystalline cellulose,
D&C Yellow No. 10,
ferrosoferric oxide,
gelatin,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about doxepin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (433)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
- Doxepin capsules, oral concentrate drug information
- Doxepin (Oral) (Advanced Reading)
- Doxepin Tablets
- Doxepin Capsules
- Doxepin Oral Concentrate
Other brands
Professional resources
- Doxepin monograph
- Doxepin (FDA)
- Doxepin Capsules (FDA)
- Doxepin Oral Solution Concentrate (FDA)
- Doxepin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.